Advertisement
Strategies can help to prevent medical practice billing errors

Guidance Provided for Preventing Practice Billing Errors

0
Practices should have a compliance plan and policy and someone responsible for enforcing it

Review Suggests Benefits of Aerobic Exercise in Fibromyalgia

0
Improvements in HRQOL, pain, fatigue, physical function; no lasting impact on HRQOL, fatigue

Revenue Exceeds Expenditures for Many ABMS Member Boards

0
Change in net balance of American Board of Medical Specialties member boards grew from 2003 to 2013

July 2017 Briefing – Rheumatology

0
Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for July 2017. This roundup includes the latest...
A comprehensive initiative

Comprehensive Initiative Has Positive Impact on Opioid Rx

0
Reductions in all tracked outcomes, including 95% drop in brand name opioid-acetaminophen products
More than one out of three average Americans used a prescription opioid in 2015

U.S. Doctors Still Writing Too Many Opioid Prescriptions

0
Nearly 92 million Americans used legitimately prescribed opioids in 2015, survey shows
In a report published in the July 28 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report

Outbreak of Septic Arthritis Described in New Jersey

0
Forty-one cases of septic arthritis linked to intra-articular injections administered at same practice
For patients with rheumatoid arthritis

Gene Expression May Predict Response to Methotrexate in RA

0
Correlations for p21, caspase 3, and RUNX2 with the change in disease activity score of 28 joints
For patients with chronic fatigue syndrome/fibromyalgia or rheumatoid arthritis

Morphine Effects Similar to Placebo in Rheumatoid Arthritis

0
Anti-hyperalgesic effects of morphine also similar to placebo in chronic fatigue/fibromyalgia
Tocilizumab (Actemra) combined with a 26-week prednisone taper is superior to either 26-week or 52-week prednisone tapering plus placebo with regard to sustained glucocorticoid-free remission in patients with giant-cell arteritis

Tocilizumab Effective for Treatment of Giant-Cell Arteritis

0
Longer follow-up called for to determine the durability of remission and safety